These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36263216)

  • 1. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
    Guan B; Huang X; Xia H; Guan G; Xu B
    Front Oncol; 2022; 12():941786. PubMed ID: 36263216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
    Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer.
    Wang Y; Chen L; Zhang B; Song W; Zhou G; Xie L; Yu D
    Front Oncol; 2021; 11():639909. PubMed ID: 33816284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
    Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
    Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
    Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
    Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Liu M; Feng Y; Zhang Y; Liu H
    Biomed Res Int; 2022; 2022():3839670. PubMed ID: 36212713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients.
    Lu S; Liu Z; Wang B; Li F; Meng Y; Wang J; Wang Y; Wang H; Zhou X; Fu W
    Cancer Cell Int; 2021 Apr; 21(1):205. PubMed ID: 33849545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Shi X; Zhao M; Shi B; Chen G; Yao H; Chen J; Wan D; Gu W; He S
    Front Oncol; 2022; 12():916840. PubMed ID: 36016621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.
    Li SF; Wei R; Yu GH; Jiang Z
    World J Gastrointest Oncol; 2022 Nov; 14(11):2224-2237. PubMed ID: 36438711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
    Sun Y; Huang Z; Chi P
    Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
    Ergen ŞA; Barlas C; Yıldırım C; Öksüz DÇ
    J Gastrointest Cancer; 2022 Mar; 53(1):151-160. PubMed ID: 33392960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yang J; Deng Q; Chen Z; Chen Y; Fu Z
    Front Oncol; 2023; 13():1242193. PubMed ID: 38074647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum uric acid, serum uric acid/serum creatinine ratio, and gamma-glutamyltransferase might predict the efficacy of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Shao Z; Xu Y; Zhang X; Zou C; Xie R
    Strahlenther Onkol; 2024 Jun; 200(6):523-534. PubMed ID: 37286741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy.
    Li S; Wang Y; Cai H; Pan Z; Guan G
    Int J Colorectal Dis; 2023 Jul; 38(1):184. PubMed ID: 37395868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
    Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P
    J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group.
    Chiloiro G; Romano A; Mariani S; Macchia G; Giannarelli D; Caravatta L; Franco P; Boldrini L; Arcelli A; Bacigalupo A; Belgioia L; Fontana A; Meldolesi E; Montesi G; Niespolo RM; Palazzari E; Piva C; Valentini V; Gambacorta MA
    Clin Transl Radiat Oncol; 2023 Mar; 39():100579. PubMed ID: 36935859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Eraslan E; Adas YG; Yildiz F; Gulesen AI; Karacin C; Arslan UY
    J Coll Physicians Surg Pak; 2021 Apr; 31(4):399-404. PubMed ID: 33866724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
    Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
    Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.